APLS
Apellis Pharmaceuticals Inc.
Latest News for APLS
In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Apellis Pharmaceuticals, with a price target of $45.00. Ac......
TD Cowen analyst Phil Nadeau maintained a Buy rating on Apellis Pharmaceuticals today and set a price target of $45.00. The company’s shares closed......
In a report released yesterday, Lisa Walter from RBC Capital maintained a Hold rating on Apellis Pharmaceuticals, with a price target of $22.00. Th......
Morgan Stanley analyst Judah Frommer maintained a Hold rating on Apellis Pharmaceuticals yesterday and set a price target of $25.00. The company’s ......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $19.61 | +0.4% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW